CBER/FDA has observed a substantial increase in the number of pre-Investigational New Drug ... products between the USA and Europe. In the USA, the US Department of Agriculture regulates the ...

As is customary, the Company must state the risk factor that the path to typical drug development of any pharmaceutical product is extremely lengthy ... CHMP refers to the Committee for Medicinal ...

As is customary, the Company must state the risk factor that the path to typical drug development of any pharmaceutical product ... refers to the Committee for Medicinal Products for Human Use ...

Veterinary pharmacovigilance involves the systematic collection, analysis, and prevention of adverse effects associated with the use of veterinary medicinal products ... drug event: lesson from Sudan ...

Lemaire, Manager, Veterinary Natural Health Product (vNHP) team Simon Adam ... Yuill announced that a new member had recently joined the vNHP Expert Advisory Committee (EAC). She invited him to ...

Alveo Technologies begins shipping test for avian influenza to EU Alveo Technologies has announced the launch of its first animal health diagnostic product ... has announced that the Committee for ...

EMA's Committee for Veterinary Medicinal Products (CVMP) has issued the first certificate for a vaccine platform technology master file (vPTMF) which will support and accelerate the development and ...

It has been a year since the FDA announced their goals for the future of animal and veterinary products in the Animal and Veterinary ... its Centers for Biologics Evaluation and Research and Drug ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

The Pharmaceutical Society of Nigeria (PSN) says there is no going back on its position on the regulation and control of the sale of veterinary drugs in the country. President of PSN, Prof.

Biogen said Thursday that the drug, known in the U.S. as Leqembi, received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use as a treatment ...

Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its Augtyro cancer drug in a pair of indications.